Bioinformatics approaches have identified that higher levels of IFIT3 gene expression found in AML patient samples, predicted poor patient prognosis, associated with immunosuppressive phenotypes and resistance to various chemotherapeutics [36]. The gene discussed is IFIT3; the disease is acute myeloid leukemia.